Rubinstein Mark Lawrence — SEC Form 4 Insider Trading Activity
Summary
Updated Jul 16, 2026
Rubinstein Mark Lawrence is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days.
Profile
Mark Lawrence Rubinstein is the Chief Medical Officer of Achieve Life Sciences, Inc., a specialty pharmaceutical company focused on cytisinicline for nicotine addiction, as disclosed in SEC filings. The most recent filing dated 2026-01-30 lists him in the Chief Medical Officer role with no reported securities transactions (purchases or sales).
Role
Insider
Notability
35/100
Board memberships
Achieve Life Sciences, Inc.
Awards & honors
Executive leadership in medical strategy for cytisinicline nicotine addiction therapy
Oversight of clinical and medical affairs for Achieve Life Sciences
Frequently Asked Questions
Who is Rubinstein Mark Lawrence?
Mark Lawrence Rubinstein is the Chief Medical Officer of Achieve Life Sciences, Inc., a specialty pharmaceutical company focused on cytisinicline for nicotine addiction, as disclosed in SEC filings. The most recent filing dated 2026-01-30 lists him in the Chief Medical Officer role with no reported securities transactions (purchases or sales).…
Where can I see all of Rubinstein Mark Lawrence's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
